DAX6.693-1,4%  Dow12.801-0,7%  Euro1,3200-0,7% 
ESt502.481-1,7%  Nas2.904-0,8%  Öl117,6-0,9% 
TDax769,9-0,4%  Nikkei8.947-0,6%  Gold1.721-0,5% 
Home > Aktien > Bentley Pharmaceuticals Aktie > Nachrichten zu Bentley Pharmaceuticals

Bentley Pharmaceuticals Aktie [WKN: 882798 / ISIN: US0826571079]

Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)News + AdhocBilanz/GuVTermineZertifikateDepot
Times + SalesChart-AnalyseAnalysenDividende/HVProfilOptionsscheineWatchlist
Börsenplätze Kursziele InsidertradesKnock-outsmyfinanzen
OrderbuchRealtime StuttgartRSS Feed im ForumFondsSenden
HistorischRealtime Push  IR-DatenAnleihen
handeln
Diese Aktie wird nicht mehr gehandelt

Hinweis

Auf dieser Seite finden Sie ALLE Nachrichten zur Bentley Pharmaceuticals Inc.. Links ausgesuchte Top-Nachrichten, rechts weitere Meldungen.

Newssuche

 GO 

ALLE Nachrichten zur Bentley Pharmaceuticals Inc.

03.07.08Bentley Pharmaceuticals & Teva Pharmaceutical Industries Ltd. Merger Consideration Established at $14.82 Per Share
01.07.08CPEX Pharmaceuticals Shares to Begin Trading Today Following Spin-off from Bentley Pharmaceuticals
01.07.08Bentley Pharmaceuticals Completes Spin-off of Drug Delivery Business
12.06.08Bentley Board Approves Spin-off of Drug Delivery Business
08.05.08Bentley Pharmaceuticals Announces First Quarter Financial Results
29.04.08Bentley Pharmaceuticals to Release First-Quarter 2008 Financial Results on May 8, 2008
31.03.08Teva kündigt Übernahme von Bentley Pharmaceuticals an
31.03.08Teva to Acquire Bentley Pharmaceuticals
13.03.08Bentley Pharmaceuticals Announces Fourth Quarter and Full Year 2007 Financial Results
29.02.08Bentley Pharmaceuticals to Release Fourth-Quarter 2007 Financial Results on March 13, 2008
13.02.08Bentley Pharmaceuticals Announces Product Approvals in Europe
11.02.08Bentley Pharmaceuticals Announces Completion of Treatment in Phase II India Clinical Study in Type 2 Diabetes and Preliminary Clinical Results
27.12.07Bentley Pharmaceuticals, Inc. Announces Initial Filing of Form 10 Registration Statement for Spin-off of Drug Delivery Business
06.11.07Bentley Pharmaceuticals Reports Third Quarter Results
01.11.07Bentley Announces Its First Product Approval in France
29.10.07Bentley Announces Product Approvals in Spain and Ireland
24.10.07Bentley Pharmaceuticals to Host Third Quarter Conference Call on November 6, 2007
23.10.07Bentley Pharmaceuticals, Inc. Announces Plans to Separate Its Two Businesses and Explore Strategic Alternatives with Respect to Its Generics Business
29.08.07Bentley Granted European Patent for Its Testosterone Gel
02.08.07Bentley Pharmaceuticals Reports Second Quarter Results
19.07.07Bentley Receives Broad U.S. Patent Protection for Its Intranasal Drug Delivery Technology
16.07.07Bentley Announces Product Approvals for Generic Pharmaceuticals
25.06.07Bentley Reports Positive Results with Nasulin(TM) Intranasal Insulin Spray at the American Diabetes Association Meeting
22.03.07Bentley Announces Approval for Tamulosin in Spain
07.03.07Bentley Announces Approval of Its First Generic Oncology Product in Spain
19.10.06Bentley Pharmaceuticals Named to Deloitte's 2006 Technology Fast 500 for the Second Year in a Row
26.09.06Bentley Pharmaceuticals Announces The Issuance of a Patent For Its Intranasal Delivery of Insulin
20.09.06Bentley Pharmaceuticals to Present at the Annual UBS Global Life Sciences Conference
19.09.06Bentley Pharmaceuticals Announces Agreement with Cardinal Health for Scale-Up and Manufacture of Clinical Supplies for Bentley's Intranasal Insulin Program
18.09.06Bentley Pharmaceuticals Named One of New England's Fastest Growing Life Sciences Companies in Deloitte's Technology Fast 50 Program
11.09.06Bentley Pharmaceuticals Names Richard P. Lindsay Vice President and CFO
03.08.06Bentley Pharmaceuticals Reports Second Quarter 2006 Results; Diluted EPS Totaled $0.12; Revenues Grew 17% to a Record $29.0 Million
27.07.06Bentley Pharmaceuticals to Host Second Quarter 2006 Conference Call and Webcast on Thursday August 3, 2006
06.07.06Bentley Pharmaceuticals Recognized as One of Fortune's 100 Fastest Growing Companies
06.06.06Bentley Pharmaceuticals to Present at The Goldman Sachs 27th Annual Global Healthcare Conference on June 13, 2006
03.05.06Bentley Pharmaceuticals to Host First Quarter 2006 Conference Call and Webcast on Wednesday May 10, 2006
01.05.06Bentley Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Healthcare Conference
10.04.06Bentley Pharmaceuticals to Present at the UBS Global Specialty Pharmaceuticals Conference on April 25, 2006
16.03.06Bentley Pharmaceuticals to Present at the CIBC Annual Biotechnology & Specialty Pharmaceuticals Conference on April 4, 2006
01.03.06Bentley Pharmaceuticals to Report Fourth Quarter and Full-Year 2005 Financial Results on March 8, 2006

Anzeige

ANZEIGE

 
Wie bewerten Sie diese Seite?
schlecht sehr gut
Aktien Prime Standard: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z DAX MDAX Dow Jones EuroStoxx

Kontakt - Impressum - Werben - Presse

finanzen.net als Startseite - Sitemap - Arbeiten bei finanzen.net - RSS-Feeds - Datenschutz - Disclaimer - Nutzungsbedingungen


Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Telekurs. Verzögerung Deutsche Börse: 15 Min., Nasdaq, NYSE: 20 Min. © 1999-2012 finanzen.net GmbH

News Aktien Kurslisten Analysen Devisen Dollarkurs Fonds Zertifikate Optionsscheine Anleihen Rohstoffe Aktien kaufen Portfolio Links Aktien China Währungsrechner Gold kaufen CFD Aktienkurse Ölpreis Leitzins Heizölpreis IPO Börsenkurse Lexikon